# SB Financial Group, Inc.: overview SBFG · Nasdaq · CIK 767405 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/sbfg.md) · [Financials](/companies/sbfg/financials.md) · [Filings](/companies/sbfg/filings.md) · [Insiders](/companies/sbfg/insiders.md) Latest reported revenue: [$775.0k](/filings/0001213900-19-022295.md) for Q3 FY2019, three months to 2019-09-30, from the 10-Q filed Nov 7, 2019 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001213900-19-022295). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.35](/filings/0001213900-25-107030.md) | not reported | [0.33](/filings/0001213900-26-053234.md) | [0.60](/filings/0001213900-26-086100.md) | [0.64](/filings/0001213900-25-107030.md) | not reported | [0.69](/filings/0001213900-26-053234.md) | [0.72](/filings/0001213900-26-086100.md) | | Free cash flow | $m | [3.2 d](/filings/0001213900-25-107030.md) | [5.7 d](/filings/0001213900-26-024471.md) | [5.8](/filings/0001213900-26-053234.md) | [(4.2) d](/filings/0001213900-26-086100.md) | [12.2 d](/filings/0001213900-25-107030.md) | [7.6 d](/filings/0001213900-26-024471.md) | [(3.2)](/filings/0001213900-26-053234.md) | [6.5 d](/filings/0001213900-26-086100.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.56](/filings/0001213900-23-018266.md) | [1.77](/filings/0001213900-24-021013.md) | [1.75](/filings/0001213900-25-021622.md) | [1.72](/filings/0001213900-26-024471.md) | [2.19](/filings/0001213900-26-024471.md) | | Free cash flow | $m | [14.8](/filings/0001213900-23-018266.md) | [23.7](/filings/0001213900-24-021013.md) | [13.0](/filings/0001213900-25-021622.md) | [8.2](/filings/0001213900-26-024471.md) | [21.4](/filings/0001213900-26-024471.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sbfg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $11.8m | 467,892 | | Reduced −2,610 | | [Cutler Capital Management, LLC](/funds/1353098.md) | 2026-06-30 | $9.8m | 387,852 | | Reduced −2,285 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.4m | 253,928 | | Reduced −43,806 | | [STRATEGIC VALUE BANK PARTNERS LLC](/funds/1904067.md) | 2026-06-30 | $6.2m | 243,628 | | Reduced −30,535 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $6.1m | 241,463 | | New +241,463 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $5.1m | 202,631 | | Added +4,859 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.0m | 158,817 | | Reduced −236,047 | | [Pinnacle Holdings, LLC](/funds/1411784.md) | 2026-06-30 | $4.0m | 156,598 | | Reduced −312 | | [Truffle Hound Capital, LLC](/funds/1595862.md) | 2026-06-30 | $2.3m | 90,373 | | New +90,373 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $2.1m | 81,511 | | Unchanged | ## Recent filings [All 934 filings](/companies/sbfg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 13:00 ET | [8-K](/filings/0001213900-26-111997.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-111997 | | 2026-10-23 | 09:49 ET | [8-K](/filings/0001213900-26-111898.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-111898 | | 2026-08-06 | 15:23 ET | [10-Q](/filings/0001213900-26-086100.md) | Quarterly report, period 2026-06-30 | 0001213900-26-086100 | | 2026-07-31 | 14:41 ET | [8-K](/filings/0001213900-26-083848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-083848 | | 2026-07-31 | 12:51 ET | [8-K](/filings/0001213900-26-083789.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-083789 | | 2026-07-17 | 16:02 ET | [8-K](/filings/0001213900-26-079156.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-079156 | | 2026-05-07 | 15:06 ET | [10-Q](/filings/0001213900-26-053234.md) | Quarterly report, period 2026-03-31 | 0001213900-26-053234 | | 2026-04-23 | 10:10 ET | [8-K](/filings/0001213900-26-046929.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-046929 | | 2026-04-22 | 15:39 ET | [8-K](/filings/0001213900-26-046586.md) | 5.07 Shareholder vote results | 0001213900-26-046586 | | 2026-04-22 | 13:01 ET | [8-K](/filings/0001213900-26-046506.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-046506 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-024471.md), filed Mar 6, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 767405 - Tickers: SBFG - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: OH - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.